CURE held its annual meeting at a June 5 BioHaven event in New Haven. Susan Froshauer, president and CEO of CURE, reviewed milestones of the past year. Rod MacKenzie, Ph.D., Senior Vice President and Head of PharmaTherapeutics R&D at Pfizer, was elected to the CURE Board. A distinguished panel of CURE executive committee members reviewed how Connecticut’s life and health sciences community is developing into a burgeoning ecosystem.